AlphaFold predicted structure
MN1 · Q10571

Mean pLDDT
42.0/ 100
Very low
1,320 residues
Confidence breakdown
- Very high(≥ 90)2%
- Confident(70–90)4%
- Low(50–70)6%
- Very low(< 50)88%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
MN1 proto-oncogene, transcriptional regulator
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownMalformations of cortical development
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownMonogenic hearing loss
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownCEBALID syndrome
hereditary disease
mathematical ability
gastric adenoma
carcinoma of liver and intrahepatic biliary tract
endometrial endometrioid adenocarcinoma
gastric carcinoma
bile duct carcinoma
breast ductal adenocarcinoma
colorectal adenocarcinoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Transcriptional activator MN1
Transcriptional activator which specifically regulates expression of TBX22 in the posterior region of the developing palate. Required during later stages of palate development for growth and medial fusion of the palatal shelves. Promotes maturation and normal function of calvarial osteoblasts, including expression of the osteoclastogenic cytokine TNFSF11/RANKL. Necessary for normal development of the membranous bones of the skull (By similarity). May play a role in tumor suppression (Probable)
MN1 · Q10571

Mean pLDDT
42.0/ 100
Very low
1,320 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0